Abstract
Background A 53-year-old man presented with left-sided flank pains to the Gastroenterology department of our clinic in September 2004. A left adrenal mass of 6.5 cm by 7.5 cm was detected by a CT scan. The patient showed no evidence of Cushing's syndrome, and had normal blood pressure and potassium levels. Endocrine tests ruled out excess levels of aldosterone or catecholamines. The patient underwent laparoscopic surgery to remove the tumor mass; histologic work-up revealed an adrenocortical carcinoma. A fluorodeoxyglucose (FDG)-PET scan 1 month, and a CT scan 8 months postoperatively showed no pathologic findings. The patient, however, again presented with left-sided flank pain to our Endocrinology department in August 2005.
Investigations In our department, laboratory work-up for endocrine activity was performed, as well as CT scans of the adrenal region, and FDG-PET scans in order to determine the extension of disease. Histologic work-up of the removed tumor tissue was performed.
Diagnosis Recurrent adrenocortical carcinoma after laparoscopic adrenalectomy.
Management In our department, 10 months after initial laparoscopic surgery, local tumor recurrence was treated by repeated extensive surgery, tumor-bed radiation therapy, and mitotane treatment. A year later, a large lymph-node metastasis was surgically removed from the lower abdomen and mitotane treatment was again started postoperatively. The patient is now scheduled for polychemotherapy because of progressive metastatic disease revealed by follow-up CT and FDG-PET scanning in June 2006.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schteingart DE et al. (2005) Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12: 667–680
Wajchenberg BL et al. (2000) Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88: 711–736
Sturgeon C and Kebebew E (2004) Laparoscopic adrenalectomy for malignancy. Surg Clin North Am 84: 755–774
Sturgeon C et al. (2006) Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? J Am Coll Surg 202: 423–430
Allolio B and Fassnacht M (2006) Clinical review: Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91: 2027–2037
Schulick RD and Brennan MF (1999) Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 6: 719–726
Pena CS et al. (2000) Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217: 798–802
Korobkin M et al. (1995) Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 197: 411–418
Sebag F et al. (2006) Isolated adrenal metastasis: the role of laparoscopic surgery. World J Surg 30: 888–892
Palazzo FF et al. (2006) Long-term outcome following laparoscopic adrenalectomy for large solid adrenal cortex tumors. World J Surg 30: 893–898
Ushiyama T et al. (1997) A case of Cushing's syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy. J Urol 157: 2239
Iino K et al. (2000) A case of adrenocortical carcinoma associated with recurrence after laparoscopic surgery. Clin Endocrinol (Oxf) 53: 243–248
Crucitti F et al. (1996) The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. Surgery 119: 161–170
Fassnacht M et al. (2006) Adjuvant radiation therapy of the tumor bed prevents local recurrences in adrenocortical carcinoma [Abstract]. In 50th Annual meeting of the German Society of Endocrinology and the 23rd meeting of the Dutch Endocrine Society: 2006 March 1–4; Essen, Germany
Kasperlik-Zaluska AA et al. (1996) Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer. Two years later. Cancer 78: 1520–1521
Berruti A et al. (2005) Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocr Relat Cancer 12: 657–666
Khan TS et al. (2000) Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use. Ann Oncol 11: 1281–1287
FIRM-ACT study [www.firm-act.org] (accessed 20 November 2006)
DeLellis RA et al. (2004) Pathology and genetics of tumours of endocrine organs. In World Health Organization Classification of Tumours, 138–159 (Eds Kleihues P and Sobin LE) Lyon: IARC Press
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Schlamp, A., Hallfeldt, K., Mueller-Lisse, U. et al. Recurrent adrenocortical carcinoma after laparoscopic resection. Nat Rev Endocrinol 3, 191–195 (2007). https://doi.org/10.1038/ncpendmet0391
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0391